Moreover, PKCα regulates Na+/K+‐ATPase (NKA)/GluR2/GLT‐1 signaling and BBB function, where excessive activation exacerbates stroke‐related damage, while appropriate modulation provides neuroprotection—highlighting its double‐edged sword nature [296]. The gene discussed is SLC1A2; the disease is stroke disorder.